We also found that the transcription factor CCAAT enhancer-binding protein alpha (CEBPA), located on chromosome 19q, played a key role in regulating the expression level of Galectin-9 in both lower-grade glioma (LGG) and glioblastoma (GBM). This evidence concerns the gene CEBPA and glioblastoma.